Medical - Berlin Symposium - PRITOR KINZAL extract

0:00
Elearning
239
1

Description

Medical - clinical trial of Pritor Kinsal

Vocal Characteristics

Language

English

Voice Age

Senior (55+)

Accents

British (General)

Transcript

Note: Transcripts are generated using speech recognition software and may contain errors.
on Target, A recently published landmark clinical trial, including 25,620 patients, investigated whether the angiotensin receptor blocker, upright or Kinzel, was non inferior to the angiotensin converting enzyme inhibitor ram. April as a therapy to prevent vascular events in high risk patients who had cardiovascular disease or diabetes but did not have heart failure. In 1/3 arm of thie on target trial, also, the combination of bright or Kinzel, with RAM April was investigated. 15 Dash Too bright or Kinzel was found to be as protective as the current gold standard. Rommie Pro in reducing the risk of cardiovascular death. Myocardial infarction stroke on hospitalisation for congestive heart failure in a broad cross section of high risk cardiovascular patients, no significant benefit was seen in the combination therapy arm of On Target that is mono therapy with either Priore Kins are or RAM April. Regarding the primary study outcomes, Priore Kinzel is the first day R B to ever show gold standard cardiovascular prevention